Delivery Order SPE2DR25D1103-SPE2DR26FE334
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Durolane 60 mg/3 ml syringes valued at $18,989.20 under a firm fixed price contract. This order, issued on November 26, 2025, with completion targeted for November 28, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger federal pharmaceutical supply agreement. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Durolane 60 mg/3 ml syringes with a ceiling value of $12.7K under firm fixed pricing. This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,565.96 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on December 5, 2025, with a completion date of December 8, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the company's corporate headquarters location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes valued at $7,568.71, with an ultimate completion date of November 13, 2025. This contract was awarded on a firm fixed-price basis without set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $10,514.15. This non-competitive, firm fixed-price delivery order is set to be completed by December 11, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a $1,679.80 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Durolane 60 mg/3 ml syringes. This competitively awarded, firm fixed-price delivery order is expected to be completed by December 4, 2025, with fulfillment occurring at the vendor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order valued at $8,063.04 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on December 8, 2025, with an ultimate completion date of December 9, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order valued at $4,949.95 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,618.97 for Durolane 60 mg/3 ml syringes on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $8,453.04 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Durolane 60 mg/3 mL syringes. This firm fixed-price contract, with a completion date of July 29, 2025, represents a competitively awarded non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The products will be delivered to AmerisourceBergen's corporate office location in...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE334Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $26,472.85 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on December 11, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 12, 2025. Durolane is a hyaluronic acid-based injectable used to treat osteoarthritis pain, making this procurement relevant to military and veteran healthcare needs managed by the Defense Health Agency. AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical supply chains, leveraging its extensive global IDC to deliver a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The non-set-aside, competitively awarded status of this delivery order reflects the contractor's demonstrated capability to meet federal procurement standards in open competition and support the Department of Defense's ongoing medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.5k | 12/10/25 |